DeutschNewstral
Article
Nnews.berkeley.edu on 2017-04-13 13:30
UC appeals U.S. patent board decision on CRISPR-Cas9
Related news
- NUC now holds largest CRISPR-Cas9 patent portfolionews.berkeley.edu
- NUC receives its 11th U.S. patent for CRISPR-Cas9news.berkeley.edu
- DUC files opening brief to appeal CRISPR-Cas9 patent decisiondailycal.org
- NEuropean Patent Office to grant UC a broad patent on CRISPR-Cas9news.berkeley.edu
- NUC receives patent for use of CRISPR-Cas9 to tune gene expressionnews.berkeley.edu
- NPatent office renews dispute over patent rights to CRISPR-Cas9news.berkeley.edu
- DUC awarded 12th patent for CRISPR-Cas9 gene-editing technologydailycal.org
- NDoudna-Charpentier team awarded U.S. patent for CRISPR-Cas9news.berkeley.edu
- DUC becomes largest CRISPR-Cas9 patent portfolio holderdailycal.org
- NU.S. patent office issues decision in CRISPR-Cas9 casenews.berkeley.edu
- NUniversity of California awarded 15th U.S. CRISPR-Cas9 patentnews.berkeley.edu
UC granted a key CRISPR patentSan Jose Mercury News- NTwelfth CRISPR patent awarded to UC teamnews.berkeley.edu
- NPatent awarded for DNA-targeting complex at heart of CRISPR-Cas9 gene editingnews.berkeley.edu
- NUC rings out 2019 with its 20th CRISPR patentnews.berkeley.edu
- NUC defends CRISPR patent rights in Court of Appealsnews.berkeley.edu
- NUC files appeal to revive CRISPR patent interferencenews.berkeley.edu
Legal battle gives Broad Institute control of patent for CRISPR/Cas9 gene-editing processThe Japan Times- NUC issued fourth CRISPR patent; three more on the waynews.berkeley.edu
- NUC awarded third CRISPR patent, expanding its gene-editing portfolionews.berkeley.edu